Ipamorelin - Beligas Pharmaceuticals

Research shows that ipamorelin’s anabolic benefits extend beyond GH secretion; it positively influences adiposity and weight gain without causing undesirable side effects on organs. In studies on mice, ipamorelin treatment increased relative fat pad weights without affecting liver size, unlike traditional GH therapy, which often leads to liver enlargement. Its unique profile of supporting fat retention in specific areas while promoting muscle growth highlights ipamorelin’s value as a more targeted and safer option compared to direct GH therapy for body composition management.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Ipamorelin by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.